Fortress Biotech, Inc.
FBIO
$2.29
$0.073.15%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.38M | 86.22M | 74.39M | 91.34M | 57.26M |
| Total Receivables | 29.94M | 18.13M | 16.20M | 18.33M | 10.40M |
| Inventory | 9.62M | 11.82M | 12.85M | 12.50M | 14.43M |
| Prepaid Expenses | 4.90M | 2.34M | 6.96M | 4.73M | 7.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.17M |
| Total Current Assets | 123.84M | 118.50M | 110.40M | 126.90M | 90.37M |
|
|
|||||
| Total Current Assets | 123.84M | 118.50M | 110.40M | 126.90M | 90.37M |
| Net Property, Plant & Equipment | 14.82M | 14.93M | 15.52M | 16.10M | 17.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 27.61M | 28.67M | 29.73M | 30.80M | 31.86M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.62M | 19.30M | 4.24M | 4.27M | 2.28M |
| Total Assets | 185.55M | 181.41M | 159.90M | 178.07M | 144.22M |
|
|
|||||
| Total Accounts Payable | 14.24M | 18.77M | 20.19M | 27.82M | 31.64M |
| Total Accrued Expenses | 30.71M | 23.99M | 25.89M | 35.87M | 30.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.13M | 7.75M | 5.89M | 4.03M | 3.25M |
| Total Finance Division Other Current Liabilities | 2.67M | 3.55M | 5.55M | 5.96M | 5.77M |
| Total Other Current Liabilities | 2.67M | 3.55M | 5.55M | 5.96M | 5.77M |
| Total Current Liabilities | 49.74M | 54.07M | 57.52M | 73.67M | 71.40M |
|
|
|||||
| Total Current Liabilities | 49.74M | 54.07M | 57.52M | 73.67M | 71.40M |
| Long-Term Debt | 52.42M | 47.77M | 50.03M | 56.38M | 57.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.67M | 12.77M | 13.30M | 13.82M | 14.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.53M | 1.62M | 1.66M | 1.71M | 1.76M |
| Total Liabilities | 123.37M | 116.22M | 122.51M | 145.59M | 145.87M |
|
|
|||||
| Common Stock & APIC | 783.92M | 785.97M | 779.89M | 773.70M | 763.60M |
| Retained Earnings | -734.05M | -730.12M | -735.97M | -751.45M | -740.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 49.87M | 55.86M | 43.92M | 22.25M | 22.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 49.87M | 55.86M | 43.92M | 22.25M | 22.73M |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | 12.31M | 9.32M | -6.54M | 10.24M | -24.38M |
| Total Equity | 62.18M | 65.19M | 37.38M | 32.49M | -1.64M |
|
|
|||||